![Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol](https://www.mdpi.com/molecules/molecules-14-03869/article_deploy/html/images/molecules-14-03869-sch001-550.jpg)
Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol
![mednotes on X: "As vitamin D is hydroxylated by kidneys to the active form, derivatives alfacalcidol or calcitrol should be used in severe renal impairment. https://t.co/06keom8JXG" / X mednotes on X: "As vitamin D is hydroxylated by kidneys to the active form, derivatives alfacalcidol or calcitrol should be used in severe renal impairment. https://t.co/06keom8JXG" / X](https://pbs.twimg.com/media/C7ebQSUWkAAlWuB.jpg)
mednotes on X: "As vitamin D is hydroxylated by kidneys to the active form, derivatives alfacalcidol or calcitrol should be used in severe renal impairment. https://t.co/06keom8JXG" / X
![Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol](https://www.mdpi.com/molecules/molecules-14-03869/article_deploy/html/images/molecules-14-03869-sch002.png)
Molecules | Free Full-Text | A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol
![Process Development for the Practical Production of Eldecalcitol by Linear, Convergent and Biomimetic Syntheses | Anticancer Research Process Development for the Practical Production of Eldecalcitol by Linear, Convergent and Biomimetic Syntheses | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/32/1/303/F1.large.jpg)
Process Development for the Practical Production of Eldecalcitol by Linear, Convergent and Biomimetic Syntheses | Anticancer Research
![Table 1 from Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease | Semantic Scholar Table 1 from Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e97aa9d1a121840f13661eefb33e2c5d418466ae/4-Table1-1.png)
Table 1 from Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease | Semantic Scholar
![Frontiers | Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study Frontiers | Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study](https://www.frontiersin.org/files/Articles/781191/fmed-08-781191-HTML/image_m/fmed-08-781191-g001.jpg)
Frontiers | Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study
![Vitamin D receptor (VDR) activation: there is an endogenous vitamin D... | Download Scientific Diagram Vitamin D receptor (VDR) activation: there is an endogenous vitamin D... | Download Scientific Diagram](https://www.researchgate.net/publication/47510462/figure/fig2/AS:267557785567280@1440802155573/Vitamin-D-receptor-VDR-activation-there-is-an-endogenous-vitamin-D-hormonal-system.png)
Vitamin D receptor (VDR) activation: there is an endogenous vitamin D... | Download Scientific Diagram
![Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol | BMC Nephrology | Full Text Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol | BMC Nephrology | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2369-10-28/MediaObjects/12882_2009_Article_137_Fig1_HTML.jpg)